SportVis Special Precautions

SportVis should only be injected by a Healthcare Professional trained in the procedure. SportVis pre-filled syringes are single use. The contents of the syringe should be used for one injection only. Any remaining sodium hyaluronate should be discarded. If a syringe is retained for a subsequent injection there is a risk of contamination resulting in the possible infection of the patient and/or foreign body reaction.
SportVis should not be resterilised as the device performance may be compromised which could cause serious harm to the patient's health and safety. SportVis must not be injected into blood vessels because sodium hyaluronate has the potential to occlude the vessels, which could result in embolism or infarction. SportVis should not be injected into a haematoma. Direct injection into tendons should be avoided as this can lead to rupture. Use of an ultrasound probe to guide the injection will minimise this risk. Do not inject into the soft tissue of patients if the area of the injection site is infected or where there is evidence of acute or chronic skin disease. Sodium hyaluronate is manufactured by fermentation of Streptococcus equi and rigorously purified. However, the Healthcare Professional should consider the immunological and other potential risks that can be associated with the injection of any biological material. There is a risk of infection at the injection site as with any periarticular procedure. There is no evidence of the safety of SportVis in human pregnancy and lactation. The safety and effectiveness of SportVis has not been tested for children below 18. Follow national or local guidelines for the safe use and disposal of needles. Obtain prompt medical attention if injury occurs. Do not use if packaging has been damaged. Do not use after the expiry date.